A drug developed at UB to treat FOXG1 syndrome has been cleared by the U.S. Food and Drug Administration to begin clinical trials. The agency approved an Investigational New Drug (IND) application for ...
A viral gene therapy developed by University at Buffalo researchers has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating children with ...
Soo-Kyung Lee, a neurodevelopmental biologist from the State University of New York at Buffalo, built her career studying transcription factors important for brain development and understanding how ...
WACONIA, Minn. (WCCO) --The cooler temperatures and changing leaves provide the perfect backdrop for marathon season in Minnesota. But for one Waconia family, race days don't end at the finish line.
BUFFALO, N.Y. — Yuna Lee, who is 10 years old, has a condition so rare that it's only documented in about 670 people around the world: a genetic mutation that wasn't apparent when she was born. But ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
A viral gene therapy has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating children with this severe neurodevelopmental disorder. A viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results